Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Central Bucks Specialists
mi
from
Doylestown, PA
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Central Bucks Specialists
mi
from
Doylestown, PA
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Cardiology Consultants of Philadelphia
mi
from
Philadelphia, PA
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Cardiology Consultants of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Mid State Medical Service
mi
from
Philipsburg, PA
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Mid State Medical Service
mi
from
Philipsburg, PA
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Buxmont Cardiology Associates
mi
from
Sellersville, PA
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Buxmont Cardiology Associates
mi
from
Sellersville, PA
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Rhode Island Heart Failure Center
mi
from
Providence, RI
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Rhode Island Heart Failure Center
mi
from
Providence, RI
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Charleston Cardiology
mi
from
Charleston, SC
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Charleston Cardiology
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
South Carolina Heart Center
mi
from
Columbia, SC
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
South Carolina Heart Center
mi
from
Columbia, SC
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Heart Specialists
mi
from
Friendswood, TX
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Heart Specialists
mi
from
Friendswood, TX
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Texas Cardiac Center
mi
from
Lubbock, TX
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Texas Cardiac Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Intermountain Medical Center
mi
from
Murray, UT
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Heart Center
mi
from
Salt Lake City, UT
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Heart Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Winchester Medical Center
mi
from
Winchester, VA
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Winchester Medical Center
mi
from
Winchester, VA
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Luther Midelfort Mayo Health Systems
mi
from
Eau Claire, WI
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Luther Midelfort Mayo Health Systems
mi
from
Eau Claire, WI
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Green Bay HeartCare
mi
from
Green Bay, WI
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Green Bay HeartCare
mi
from
Green Bay, WI
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
Regions Hospital Cardiology Research
mi
from
Saint Paul, MN
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
Regions Hospital Cardiology Research
mi
from
Saint Paul, MN
Click here to add this to my saved trials
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated:  1/25/2018
St. Paul Cardiology
mi
from
Saint Paul, MN
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure
Status: Enrolling
Updated: 1/25/2018
St. Paul Cardiology
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Using Feedback Reports to Improve Medication Adherence
Evaluating Individual and Patient-Selected Family/Friend/or Reciprocal Peer Notifications to Improve Statin Medication Adherence Among Patients With Coronary Artery Disease
Status: Enrolling
Updated:  1/26/2018
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Using Feedback Reports to Improve Medication Adherence
Evaluating Individual and Patient-Selected Family/Friend/or Reciprocal Peer Notifications to Improve Statin Medication Adherence Among Patients With Coronary Artery Disease
Status: Enrolling
Updated: 1/26/2018
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Frailty in Children With Cardiac Disease
Frailty in Children With Cardiac Disease: A Pilot Study
Status: Enrolling
Updated:  1/27/2018
Children's Mercy Hospital
mi
from
Kansas City, MO
Frailty in Children With Cardiac Disease
Frailty in Children With Cardiac Disease: A Pilot Study
Status: Enrolling
Updated: 1/27/2018
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements
A Prospective Double-Blinded Clinical Trial Using Apatone®B for Care and Treatment of Proven Non-Infected Symptomatic Postoperative Total Joint Arthroplasties
Status: Enrolling
Updated:  1/29/2018
Summa Health System
mi
from
Akron, OH
Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements
A Prospective Double-Blinded Clinical Trial Using Apatone®B for Care and Treatment of Proven Non-Infected Symptomatic Postoperative Total Joint Arthroplasties
Status: Enrolling
Updated: 1/29/2018
Summa Health System
mi
from
Akron, OH
Click here to add this to my saved trials
Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
Methods to Augment the Efficacy of Aspirin and Clopidogrel in Healthy Subjects (ASA Only) and Patients With Stable Coronary Artery Disease (Taking Clopidogrel Only) or (Taking Clopidogrel & ASA) With an Elevated Platelet Turnover (Reticulated Platelets).
Status: Enrolling
Updated:  1/29/2018
Methodist Hospital
mi
from
Houston, TX
Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
Methods to Augment the Efficacy of Aspirin and Clopidogrel in Healthy Subjects (ASA Only) and Patients With Stable Coronary Artery Disease (Taking Clopidogrel Only) or (Taking Clopidogrel & ASA) With an Elevated Platelet Turnover (Reticulated Platelets).
Status: Enrolling
Updated: 1/29/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Status: Enrolling
Updated:  1/29/2018
Methodist Hospital
mi
from
Houston, TX
Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Status: Enrolling
Updated: 1/29/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients
Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients
Status: Enrolling
Updated:  1/30/2018
Baylor College of Medicine
mi
from
Houston, TX
Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients
Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients
Status: Enrolling
Updated: 1/30/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Status: Enrolling
Updated:  1/31/2018
Arizona Pediatric Cardiology Consultants
mi
from
Phoenix, AZ
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Status: Enrolling
Updated: 1/31/2018
Arizona Pediatric Cardiology Consultants
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Status: Enrolling
Updated:  1/31/2018
Children's Cardiology Associates
mi
from
Austin, TX
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Status: Enrolling
Updated: 1/31/2018
Children's Cardiology Associates
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Barrow Neurological Institute
mi
from
Phoenix, AZ
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Rush University Medical Center
mi
from
Chicago, IL
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
University of Maryland Medical Cnter
mi
from
Baltimore, MD
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
University of Maryland Medical Cnter
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Hackensack University Medical Center
mi
from
Hackensack, NJ
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Overlook Medical Center
mi
from
Summit, NJ
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Overlook Medical Center
mi
from
Summit, NJ
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
University of New Mexico
mi
from
Albuquerque, NM
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Columbia University
mi
from
New York, NY
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Lenox Hill Hospital
mi
from
New York, NY
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Lenox Hill Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Mount Sinai Hospital
mi
from
New York, NY
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Mayfield Clinic
mi
from
Cincinnati, OH
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Mayfield Clinic
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Oregon Health and Science University
mi
from
Portland, OR
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Medical University of South Carolina
mi
from
Charleston, SC
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
Vanderbilt University
mi
from
Nashville, TN
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/31/2018
University of Calgary/Foothills Medical Centre
mi
from
Calgary,
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/31/2018
University of Calgary/Foothills Medical Centre
mi
from
Calgary,
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
University of Colorado, Boulder
mi
from
Boulder, CO
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
University of Colorado, Boulder
mi
from
Boulder, CO
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
Yale University Prevention Research Center
mi
from
Derby, CT
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
Yale University Prevention Research Center
mi
from
Derby, CT
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
Boston University
mi
from
Boston, MA
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
University of Western Ontario
mi
from
London,
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
University of Western Ontario
mi
from
London,
Click here to add this to my saved trials
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated:  2/1/2018
University of Maryland School of Medicine
mi
from
Baltimore, MD
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated: 2/1/2018
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated:  2/1/2018
Sinai Center for Thrombosis Research
mi
from
Baltimore, MD
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated: 2/1/2018
Sinai Center for Thrombosis Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated:  2/1/2018
Christiana Care Health System
mi
from
Newark, DE
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated: 2/1/2018
Christiana Care Health System
mi
from
Newark, DE
Click here to add this to my saved trials
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated:  2/1/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated: 2/1/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials